| Literature DB >> 30391967 |
Mustafa Serkan Durdu1, Çağdaş Baran, Fatih Gümüş, Gökay Deniz, Mehmet Çakıcı, Evren Özçınar, Ahmet Onat Bermede, Kemalettin Uçanok, Ahmet Rüçhan Akar.
Abstract
OBJECTIVE: All innovations in cardiac surgery provide us with new techniques to perform surgery through smaller incisions with less invasive and best cosmetic results. After promising results in minimally invasive cardiac surgery (MICS), pain and cosmetic appearance became important end points, especially for female patients. In the current study, we intended to evaluate the surgical results and cosmetic satisfaction with the periareolar and submammary incision types in cardiac surgery.Entities:
Mesh:
Year: 2018 PMID: 30391967 PMCID: PMC6280288 DOI: 10.14744/AnatolJCardiol.2018.37200
Source DB: PubMed Journal: Anatol J Cardiol ISSN: 2149-2263 Impact factor: 1.596
Figure 1Preoperative surgical marks (Ia), external aspect of the operative field (Ib), postoperative periareolar closure view (Ic), wound aspect on the 7th postoperative day (IIa), the final aspect of the periareolar access on the 45th postoperative day (IIb, IIc)
Figure 2Preoperative evaluation of computed tomography
Baseline characteristics before minimally invasive cardiac surgery
| Variables | Periareolar (n=62) | Submammarian (n=32) | |
|---|---|---|---|
| Age | 41.23±12.2 | 40.5±11.63 | 0.712 |
| BSA (kg/m2) | 1.71±0.3 | 1.68±0.22 | 0.623 |
| Smoking | 19 (30.6%) | 9 (28.1%) | 0.818 |
| Hypertension | 26 (41.9%) | 12 (37.5%) | 0.514 |
| Diabetes | 3 (4.8%) | 1 (3.1%) | 0.924 |
| Hyperlipidemia | 8 (12.9%) | 4 (12.5%) | 0.876 |
| Total cholesterol (mg/dL) | 168.4±28.4 | 171.2±25.2 | 0.643 |
| LDL cholesterol (mg/dL) | 124.6±16.2 | 119.8±14.6 | 0.115 |
| HDL cholesterol (mg/dL) | 42.1±7.2 | 40.8±9.4 | 0.412 |
| COPD | 5 (8%) | 3 (9.3%) | 0.865 |
| PVD | 1 (1.6%) | - | 0.792 |
| C-reactive protein (mg/L) | 2.1±1.2 | 2.3±1.1 | 0.445 |
| LVEDD (mm) | 46.3±3.5 | 45.8±3.2 | 0.552 |
| LVESD (mm) | 28.2±4.4 | 27.6±4.2 | 0.514 |
| LVEF (%) | 60.5±11 | 58.1±14 | 0.516 |
| Systolic PAP (mm Hg) | 35.8±17.8 | 37.2±18.1 | 0.719 |
| LA diameter (mm) | 44.2±8.2 | 43.8±6.8 | 0.819 |
| AF | 21 (33.8%) | 9 (28.3%) | 0.553 |
| Tricuspid regurgitation >2 | 20 (32.2%) | 10 (31.2%) | 0.982 |
| NYHA >Class 2 | 19 (30.6%) | 9 (28.1%) | 0.824 |
| Euro Score II (%) | 1.36±0.12 | 1.34±0.16 | 0.421 |
| Preoperative antiplatelet/warfarin | 21 (33.8%) | 9 (28.1%) | 0.551 |
| β-blocker | 19 (30.6%) | 9 (28.1%) | 0.843 |
| Ace inhibitor or ARB | 20 (32.2%) | 13 (40.6%) | 0.443 |
| Antihyperlipidemic | 8 (12.9%) | 4 (12.5%) | 0.982 |
| Digoxin | 2 (3.2%) | 2 (6.2%) | 0.643 |
| Diuretics | 10 (16.1%) | 8 (25%) | 0.421 |
| Thorax size (cm) | 5.83±0.5 | 5.79±0.6 | 0.751 |
Continuous data are presented as mean±standard deviation and discrete data as percentage.
BMI - body mass index, AF - atrial fibrillation, ARB - angiotensin receptor blocker, COPD - chronic obstructive pulmonary disease, EF - ejection fraction, HDL - high-density lipoprotein, LDL - low-density lipoprotein, NYHA - New York Heart Association, LVEF - left ventricular ejection fraction
Operative procedural information
| Variables | Group A (62) | Group B (32) | |
|---|---|---|---|
| Time to access 4th subcostal (min) | 6±2.8 | 2±0.8 | 0.0001 |
| MVR/R | 24 | 14 | 0.621 |
| MVR/R+TRA | 20 | 10 | 0.976 |
| ASD repair | 18 | 8 | 0.824 |
| RF ablation | 21 (33.8%) | 9 (28.1%) | 0.556 |
| CPB time (min) | 75.1±9.3 | 72.6±8.7 | 0.267 |
| Cross-clamp time (min) | 31.4±3.7 | 30.8±4.2 | 0.443 |
| Mortality | none | none | - |
| Bleeding/Revision | 1 | 0 | - |
MVR/R - mitral valve replacement/repair, TRA - tricuspid ring annuloplasty, ASD - atrial septal defect, CBP - cardiopulmonary bypass
Postoperative data
| Variables | Periareolar (62) | Submammarian (32) | |
|---|---|---|---|
| Incision size (cm) | 5.6±0.6 | 6.7±0.8 | 0.0001 |
| Scar size (cm) | 4.3±0.4 | 5.3±0.2 | 0.0001 |
| Nipple numbness | 3 | 2 | - |
| Breast hematoma | 1 | none | - |
| Superficial wound infection | none | 4 | 0.012 |
| Discharge (day) | 4.4 | 4.6 | 0.432 |
| Pain level | 3.2±0.7 | 3.4±0.9 | 0.221 |